Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Investors pump $200M into Intarcia's PhIII for once-yearly diabetes therapy
Investors pump $200M into Intarcia's PhIII for once-yearly diabetes therapy
Investors pump $200M into Intarcia's PhIII for once-yearly diabetes therapy
Submitted by
admin
on April 1, 2014 - 3:34pm
Source:
First Word Pharma
News Tags:
diabetes
Intarcia
exenatide
Headline:
Investors pump $200M into Intarcia's PhIII for once-yearly diabetes therapy
Do Not Allow Advertisers to Use My Personal information
